Sperm DNA fragmentation: a rationale for its clinical utility

Affiliations

¹ Department of Urology, Hamad Medical Corporation, Doha, Qatar.
² American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH, USA.
³ ANDROFERT, Andrology and Human Reproduction Clinic, Referral Center for Male Reproduction, Campinas, SP, Brazil.

Editorial

Ahmad Majzoub et al. Transl Androl Urol. 2017 Sep.

. 2017 Sep;6(Suppl 4):S455-S456.

doi: 10.21037/tau.2017.03.63.

¹ Department of Urology, Hamad Medical Corporation, Doha, Qatar.
² American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH, USA.
³ ANDROFERT, Andrology and Human Reproduction Clinic, Referral Center for Male Reproduction, Campinas, SP, Brazil.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Pros and cons of sperm DNA fragmentation testing: weighing the evidence.
Mehta A. Mehta A. Transl Androl Urol. 2017 Sep;6(Suppl 4):S453-S454. doi: 10.21037/tau.2017.03.71. Transl Androl Urol. 2017. PMID: 29082160 Free PMC article. No abstract available.

1. Agarwal A, Majzoub A, Esteves SC, et al. Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios. Transl Androl Urol 2016;5:935-50. 10.21037/tau.2016.10.03 - DOI - PMC - PubMed
1. Agarwal A, Cho CL, Esteves SC. Should we evaluate and treat sperm DNA fragmentation? Curr Opin Obstet Gynecol 2016;28:164-71. 10.1097/GCO.0000000000000271 - DOI - PubMed
1. Agarwal A, Said TM. Role of sperm chromatin abnormalities and DNA damage in male infertility. Hum Reprod Update 2003;9:331-45. 10.1093/humupd/dmg027 - DOI - PubMed
1. Sharma RK, Said T, Agarwal A. Sperm DNA damage and its clinical relevance in assessing reproductive outcome. Asian J Androl 2004;6:139-48. - PubMed
1. Bungum M, Humaidan P, Axmon A, et al. Sperm DNA integrity assessment in prediction of assisted reproduction technology outcome. Hum Reprod 2007;22:174-9. 10.1093/humrep/del326 - DOI - PubMed